Scinus Cell Expansion
PrivateLast Round
Strategic
Mar 10, 2026
Total Funding Raised
$3.49M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Scinus Cell Expansion operates in Healthcare & Life Sciences and is based in Zeist. Its latest recorded funding round was a Strategic round in March 2026.
Scinus Cell Expansion is a biotechnology company that develops and distributes a bioreactor technology platform for stem cell cultivation, intended to make cell therapies accessible globally.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scinus Cell Expansion Comparables
Compare Scinus Cell Expansion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aglaris | 88% | |
| BioThrust | 87% | |
| Cellex | 87% |
For institutional investors. Book with your work email.
Scinus Cell Expansion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 10, 2026 | ||||
| Strategic | Jun 13, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scinus Cell Expansion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Myosotis Investments | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Raised $3.5M led by Myosotis Investments
- Dec 25, 2025
Grew 23% QoQ from 13 to 16 employees.
For institutional investors. Book with your work email.
Scinus Cell Expansion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scinus Cell Expansion's valuation, stock price, and market status.
Is Scinus Cell Expansion a public or private company?
Scinus Cell Expansion is a private company.
What is the current stock price of Scinus Cell Expansion?
Scinus Cell Expansion is a private company, so its shares have no public market price. Caplight tracks Scinus Cell Expansion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scinus Cell Expansion worth (valuation)?
Valuation information for Scinus Cell Expansion is not publicly available.
Can I buy Scinus Cell Expansion stock?
Scinus Cell Expansion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scinus Cell Expansion's last funding round?
Scinus Cell Expansion's most recent funding round was Strategic on March 10, 2026.
Who are the main investors in Scinus Cell Expansion?
Key investors in Scinus Cell Expansion include Myosotis Investments.
Will Scinus Cell Expansion IPO soon?
No public IPO plans have been announced for Scinus Cell Expansion.
How can I track Scinus Cell Expansion secondary market activity?
Caplight tracks bids, offers, and trades in Scinus Cell Expansion's shares on secondary markets.